Royal Bank of Canada’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.8M | Buy |
797,585
+2,650
| +0.3% | +$45.9K | ﹤0.01% | 1628 |
|
|
2025
Q1 | $17.4M | Sell |
794,935
-723,892
| -48% | -$15.8M | ﹤0.01% | 1251 |
|
|
2024
Q4 | $48.5M | Buy |
1,518,827
+1,376,832
| +970% | +$43.9M | 0.01% | 777 |
|
|
2024
Q3 | $4.1M | Buy |
141,995
+9,034
| +7% | +$261K | ﹤0.01% | 2152 |
|
|
2024
Q2 | $5.1M | Buy |
132,961
+31,627
| +31% | +$1.21M | ﹤0.01% | 1947 |
|
|
2024
Q1 | $5.96M | Sell |
101,334
-16,276
| -14% | -$957K | ﹤0.01% | 1820 |
|
|
2023
Q4 | $7.04M | Sell |
117,610
-1,054
| -0.9% | -$63.1K | ﹤0.01% | 1704 |
|
|
2023
Q3 | $4.51M | Sell |
118,664
-21,821
| -16% | -$830K | ﹤0.01% | 1876 |
|
|
2023
Q2 | $12.8M | Buy |
140,485
+3,242
| +2% | +$295K | ﹤0.01% | 1250 |
|
|
2023
Q1 | $9.05M | Buy |
137,243
+33,927
| +33% | +$2.24M | ﹤0.01% | 1436 |
|
|
2022
Q4 | $5.34M | Buy |
103,316
+29,097
| +39% | +$1.5M | ﹤0.01% | 1807 |
|
|
2022
Q3 | $5.07M | Sell |
74,219
-7,953
| -10% | -$543K | ﹤0.01% | 1784 |
|
|
2022
Q2 | $3.72M | Sell |
82,172
-7,610
| -8% | -$344K | ﹤0.01% | 2050 |
|
|
2022
Q1 | $4.56M | Sell |
89,782
-15,408
| -15% | -$783K | ﹤0.01% | 2022 |
|
|
2021
Q4 | $4.97M | Buy |
105,190
+13,309
| +14% | +$629K | ﹤0.01% | 2034 |
|
|
2021
Q3 | $3.03M | Buy |
91,881
+6,232
| +7% | +$205K | ﹤0.01% | 2373 |
|
|
2021
Q2 | $5.41M | Sell |
85,649
-2,124
| -2% | -$134K | ﹤0.01% | 2006 |
|
|
2021
Q1 | $3.77M | Buy |
87,773
+4,104
| +5% | +$176K | ﹤0.01% | 2157 |
|
|
2020
Q4 | $4.79M | Sell |
83,669
-8,396
| -9% | -$480K | ﹤0.01% | 1917 |
|
|
2020
Q3 | $2.78M | Buy |
92,065
+19,568
| +27% | +$590K | ﹤0.01% | 2097 |
|
|
2020
Q2 | $2.37M | Sell |
72,497
-1,785
| -2% | -$58.3K | ﹤0.01% | 2173 |
|
|
2020
Q1 | $1.99M | Sell |
74,282
-2,226
| -3% | -$59.6K | ﹤0.01% | 2146 |
|
|
2019
Q4 | $2.34M | Sell |
76,508
-87
| -0.1% | -$2.66K | ﹤0.01% | 2300 |
|
|
2019
Q3 | $1.85M | Sell |
76,595
-9,301
| -11% | -$224K | ﹤0.01% | 2374 |
|
|
2019
Q2 | $2.18M | Sell |
85,896
-4,471
| -5% | -$113K | ﹤0.01% | 2268 |
|
|
2019
Q1 | $1.76M | Buy |
90,367
+13,092
| +17% | +$255K | ﹤0.01% | 2363 |
|
|
2018
Q4 | $1.02M | Buy |
77,275
+28,033
| +57% | +$370K | ﹤0.01% | 2624 |
|
|
2018
Q3 | $875K | Buy |
49,242
+43,500
| +758% | +$773K | ﹤0.01% | 2947 |
|
|
2018
Q2 | $127K | Buy |
5,742
+5,740
| +287,000% | +$127K | ﹤0.01% | 4105 |
|
|
2018
Q1 | $0 | Sell |
2
-96
| -98% | – | ﹤0.01% | 5685 |
|
|
2017
Q4 | $2K | Buy |
+98
| New | +$2K | ﹤0.01% | 5492 |
|